GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » ARYA Sciences Acquisition Corp III (NAS:ARYA) » Definitions » 12-1 Month Momentum %

ARYA Sciences Acquisition III (ARYA Sciences Acquisition III) 12-1 Month Momentum % : N/A% (As of May. 08, 2024)


View and export this data going back to 2020. Start your Free Trial

What is ARYA Sciences Acquisition III 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-08), ARYA Sciences Acquisition III's 12-1 Month Momentum % is N/A%.

The industry rank for ARYA Sciences Acquisition III's 12-1 Month Momentum % or its related term are showing as below:

ARYA's 12-1 Month Momentum % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 4.7
* Ranked among companies with meaningful 12-1 Month Momentum % only.

Competitive Comparison of ARYA Sciences Acquisition III's 12-1 Month Momentum %

For the Shell Companies subindustry, ARYA Sciences Acquisition III's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ARYA Sciences Acquisition III's 12-1 Month Momentum % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, ARYA Sciences Acquisition III's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where ARYA Sciences Acquisition III's 12-1 Month Momentum % falls into.



ARYA Sciences Acquisition III  (NAS:ARYA) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ARYA Sciences Acquisition III  (NAS:ARYA) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


ARYA Sciences Acquisition III 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of ARYA Sciences Acquisition III's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


ARYA Sciences Acquisition III (ARYA Sciences Acquisition III) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
51 Astor Place, 10th Floor, New York, NY, USA, 10003
Website
ARYA Sciences Acquisition Corp III is a blank check company.
Executives
Adam Leo Stone director, 10 percent owner, officer: Chief Executive Officer C/O SOLID BIOSCIENCES, LLC, 141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE MA 02139
Michael Seth Altman director, 10 percent owner, officer: Chief Financial Officer C/O PERCEPTIVE ADVISORS, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Arya Sciences Holdings Iii 10 percent owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Saqib Islam director ALEXION PHARMACEUTICALS, 352 KNOTTER DRIVE, CHESHIRE CT 06410
Joseph Edelman director C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Todd Wider director 4848 LEMMON AVENUE, SUITE 517, DALLAS TX 75219
Bradley L Campbell director C/O AMICUS THERAPEUTICS, INC., 1 CEDAR BROOK DRIVE, CRANBURY NJ 08512
Konstantin Poukalov officer: Chief Business Officer C/O KADMON HOLDINGS, LLC, 450 E 29TH STREET, NEW YORK NY 10016